IL22 and neoplasm: IL-36γ, together with IL-17α or IL-22, synergistically induces the expression of different genes involved in the IL-17/IL-23 axis and additively induces colon cancer cell proliferation [25], supporting a tumor-promoting role for inflammatory factors, such as IL-22 and IL-36, in CRC.